Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,853 | 98,745 | 167,630 | 299,500 | 364,618 |
| Marketable Securities | 170,676 | 179,145 | 95,111 | 44,548 | N/A |
| Receivables | 62,509 | 60,588 | 55,928 | 48,864 | 29,760 |
| Inventories | 48,428 | 43,893 | 60,877 | 48,154 | 32,171 |
| TOTAL | $391,996 | $396,446 | $392,060 | $454,020 | $431,733 |
| Non-Current Assets | |||||
| PPE Net | 18,009 | 17,962 | 18,405 | 13,682 | 5,851 |
| Intangibles | 33,518 | 36,791 | 39,267 | 14,475 | 14,883 |
| Other Non-Current Assets | 18,019 | 48,301 | 44,725 | 37,299 | 10,838 |
| TOTAL | $69,546 | $103,054 | $102,397 | $65,456 | $31,572 |
| Total Assets | $461,542 | $499,500 | $494,457 | $519,476 | $463,305 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,410 | 5,529 | 3,032 | 4,805 | 3,034 |
| Accrued Expenses | 23,417 | 21,443 | 20,035 | 21,126 | 15,251 |
| Other current liabilities | 19,473 | 15,199 | 10,464 | 10,123 | 7,815 |
| TOTAL | $77,804 | $67,663 | $56,226 | $49,040 | $33,181 |
| Non-Current Liabilities | |||||
| Long Term Debt | 525 | 1,050 | 1,648 | 2,271 | N/A |
| Deferred Revenues | 28,504 | 25,492 | 22,695 | 12,986 | 7,081 |
| Other Non-Current Liabilities | 23,135 | 18,952 | 28,387 | 29,587 | 14,923 |
| TOTAL | $41,999 | $36,100 | $45,167 | $44,890 | $24,739 |
| Total Liabilities | $119,803 | $103,763 | $101,393 | $93,930 | $57,920 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,550 | 128,097 | 130,824 | 135,431 | 134,077 |
| Common Shares | 129 | 129 | 131 | 135 | 126 |
| Retained earnings | -101,738 | -35,199 | -29,178 | -17,030 | -19,606 |
| Other shareholders' equity | 2,241 | 16 | -1,275 | -446 | 1,240 |
| TOTAL | $341,739 | $395,737 | $393,064 | $425,546 | $405,385 |
| Total Liabilities And Equity | $461,542 | $499,500 | $494,457 | $519,476 | $463,305 |